Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma
US5730983A · kind A · utility
14Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 19, 1994 |
| Grant date | Mar 24, 1998 |
| Priority date | — |
| Expiry date | May 19, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/868
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of intercellular adhesion molecule-1 (ICAM-1) or fragments thereof, anti-CD18 antibodies or fragments thereof, and members of the CD18 family of proteins or fragments thereof in the treatment of asthma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.